Orkay,True,2019-02-21 14:16:00,124.905,MDGL given GILD failure and ICPT notsoimpressive results expecting MDGL to 200 soon after they announce Ph3 start
DJ_CV91913,,2019-02-21 13:18:00,125.68,ALDX Check out Aldeyra today MDGL ICPT SQ EA TSLA TVIX IMDZ KNDI MLNX NIO AMGN TEVA CGC WDAY
DJ_CV91913,,2019-02-21 10:15:00,122,VKTX With GILD and ICPT seen as nonviable commercially MDGL is inferior to VKTX from a phase 2 results comparison T minus 10
Orkay,True,2019-02-21 10:13:00,122.022,MDGL We expect to begin a Phase 3 study in NASH in late 2018 or early 2019 subject to regulatory approval from Q4 report
